Evaluation of a Gadolinium-Based Nanoparticle (AGuIX) for Contrast-Enhanced MRI of the Liver in a Rat Model of Hepatic Colorectal Cancer Metastases at 9.4 Tesla-Reference-Cited by-同舟云学术

Evaluation of a Gadolinium-Based Nanoparticle (AGuIX) for Contrast-Enhanced MRI of the Liver in a Rat Model of Hepatic Colorectal Cancer Metastases at 9.4 Tesla

Published:2015-09-11 Issue:12 Volume:187 Page:1108-1115
ISSN:1438-9029
Container-title:RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
language:de
Short-container-title:Fortschr Röntgenstr

Author:

Fries P.¹,Morr D.¹,Müller A.¹,Lux F.²,Tillement O.²,Massmann A.¹,Seidel R.¹,Schäfer T.³,Menger M.⁴,Schneider G.¹,Bücker A.¹

Affiliation:

1. Clinic of Diagnostic and Interventional Radiology, Saarland University Medical Center, Homburg, Germany

2. Laboratoire de Physico-Chimie des Matériaux Luminescents, Université Claude Bernard, Lyon, France

3. Department of General, Visceral and Pediatric Surgery, Saarland University Medical Center, Homburg, Germany

4. Institute for Clinical and Experimental Surgery, Saarland University Medical Center, Homburg, Germany

Publisher

Georg Thieme Verlag KG

Subject

Radiology, Nuclear Medicine and imaging

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0035-1553500.pdf

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical transfer of AGuIX®-based radiation treatments for locally advanced cervical cancer: MR quantification and in vitro insights in the NANOCOL clinical trial framework;Nanomedicine: Nanotechnology, Biology and Medicine;2023-06

2. Effect of metal complexation on the radiolytic stability of DOTA;Dalton Transactions;2023

3. Nanoparticles for MRI-guided radiation therapy: a review;Cancer Nanotechnology;2022-11-12

4. Targeting brain metastases with ultrasmall theranostic nanoparticles, a first-in-human trial from an MRI perspective;Science Advances;2020-07-17

5. EPR-mediated tumor targeting using ultrasmall-hybrid nanoparticles: From animal to human with theranostic AGuIX nanoparticles;Theranostics;2020